{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:25:27Z","timestamp":1787934327165,"version":"build-2784847793"},"reference-count":112,"publisher":"Bentham Science Publishers Ltd.","issue":"28","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Atherosclerosis and one of its most serious consequences, coronary artery disease, are important sources of morbidity and mortality globally, necessitating early detection and treatment. Considering their complex pathophysiology, including several harmful processes, a comprehensive approach to diagnosis, prognosis, and therapy is very desirable. Extracellular matrix remodeling is a major component of this dangerous cascade, including the cleavage of constituents (collagen, elas-tin, proteoglycans) and the propagation or exacerbation of the inflammatory response. Several ex-tracellular matrix degradation indicators have been hypothesized to correlate with the existence, se-verity, and prognosis of coronary artery disease. The potency of matrix metalloproteinases, notably collagenases and gelatinases, has been the most thoroughly investigated in clinical studies. Strome-lysins, matrilysins, transmembrane matrix metalloproteinases, collagen and laminin turnover indica-tors, as well as fibronectin, have also been studied to a lesser level. Among the most well-studied markers, MMP-1, MMP-2, MMP-8, and MMP-9 have been found increased in patients with cardio-vascular risk factors such as metabolic syndrome, its components (obesity, dyslipidemia, diabetes mellitus), and smoking. Increasing concentrations are detected in acute coronary syndromes com-pared to stable angina pectoris and healthy control groups. It should also be stressed that those ex-tracellular matrix biomarkers may also be detected in high concentrations in other vascular patholo-gies such as peripheral artery disease, carotid artery disease, aortic aneurysms, and dissections. De-spite the advances gained, future research should focus on their importance and, more crucially, their added utility as biomarkers in identifying persons at risk of developing overt coronary artery disease. At the same time, determining the prognosis of coronary artery disease patients using such biomarkers may be important for their adequate care.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1568026623666221024091758","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T04:30:15Z","timestamp":1666758615000},"page":"2355-2367","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Extracellular Matrix Remodeling Biomarkers in Coronary Artery Disease"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9260-6306","authenticated-orcid":true,"given":"Panagiotis","family":"Theofilis","sequence":"first","affiliation":[{"name":"1st Cardiology Department, Hippokration General Hospital, University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Sagris","sequence":"additional","affiliation":[{"name":"1st Cardiology Department, Hippokration General Hospital, University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Oikonomou","sequence":"additional","affiliation":[{"name":"1st Cardiology Department, Hippokration General Hospital, University of Athens Medical School, Athens, Greece"},{"name":"3rd Cardiology Department, Sotiria Chest Disease Hospital, University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexios S","family":"Antonopoulos","sequence":"additional","affiliation":[{"name":"1st Cardiology Department, Hippokration General Hospital, University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Lazaros","sequence":"additional","affiliation":[{"name":"1st Cardiology Department, Hippokration General Hospital, University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Theofilis","sequence":"additional","affiliation":[{"name":"1st Cardiology Department, Hippokration General Hospital, University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Papastamos","sequence":"additional","affiliation":[{"name":"1st Cardiology Department, Hippokration General Hospital, University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyridon","family":"Papaioannou","sequence":"additional","affiliation":[{"name":"Cardiology Department, Athens Naval and Veterans Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Siasos","sequence":"additional","affiliation":[{"name":"1st Cardiology Department, Hippokration General Hospital, University of Athens Medical School, Athens, Greece"},{"name":"3rd Cardiology Department, Sotiria Chest Disease Hospital, University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Tsioufis","sequence":"additional","affiliation":[{"name":"1st Cardiology Department, Hippokration General Hospital, University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Tousoulis","sequence":"additional","affiliation":[{"name":"1st Cardiology Department, Hippokration General Hospital, University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"Roth G.A.","year":"2020","unstructured":"Roth G.A.; Mensah G.A.; Johnson C.O.; Addolorato G.; Ammirati E.; Baddour L.M.; Barengo N.C.; Beaton A.Z.; Benjamin E.J.; Benziger C.P.; Bonny A.; Brauer M.; Brodmann M.; Cahill T.J.; Carapetis J.; Catapano A.L.; Chugh S.S.; Cooper L.T.; Coresh J.; Criqui M.; DeCleene N.; Eagle K.A.; Emmons-Bell S.; Feigin V.L.; Fern&#xE1;ndez-Sol&#xE0; J.; Fowkes G.; Gakidou E.; Grundy S.M.; He F.J.; Howard G.; Hu F.; Inker L.; Karthikeyan G.; Kassebaum N.; Koroshetz W.; Lavie C.; Lloyd-Jones D.; Lu H.S.; Mirijello A.; Temesgen A.M.; Mokdad A.; Moran A.E.; Muntner P.; Narula J.; Neal B.; Ntsekhe M.; Moraes de Oliveira G.; Otto C.; Owolabi M.; Pratt M.; Rajagopalan S.; Reitsma M.; Ribeiro A.L.P.; Rigotti N.; Rodgers A.; Sable C.; Shakil S.; Sliwa-Hahnle K.; Stark B.; Sundstr&#xF6;m J.; Timpel P.; Tleyjeh I.M.; Valgimigli M.; Vos T.; Whelton P.K.; Yacoub M.; Zuhlke L.; Murray C.; Fuster V.; Roth G.A.; Mensah G.A.; Johnson C.O.; Addolorato G.; Ammirati E.; Baddour L.M.; Barengo N.C.; Beaton A.; Benjamin E.J.; Benziger C.P.; Bonny A.; Brauer M.; Brodmann M.; Cahill T.J.; Carapetis J.R.; Catapano A.L.; Chugh S.; Cooper L.T.; Coresh J.; Criqui M.H.; DeCleene N.K.; Eagle K.A.; Emmons-Bell S.; Feigin V.L.; Fern&#xE1;ndez-Sola J.; Fowkes F.G.R.; Gakidou E.; Grundy S.M.; He F.J.; Howard G.; Hu F.; Inker L.; Karthikeyan G.; Kassebaum N.J.; Koroshetz W.J.; Lavie C.; Lloyd-Jones D.; Lu H.S.; Mirijello A.; Misganaw A.T.; Mokdad A.H.; Moran A.E.; Muntner P.; Narula J.; Neal B.; Ntsekhe M.; Oliveira G.M.M.; Otto C.M.; Owolabi M.O.; Pratt M.; Rajagopalan S.; Reitsma M.B.; Ribeiro A.L.P.; Rigotti N.A.; Rodgers A.; Sable C.A.; Shakil S.S.; Sliwa K.; Stark B.A.; Sundstr&#xF6;m J.; Timpel P.; Tleyjeh I.I.; Valgimigli M.; Vos T.; Whelton P.K.; Yacoub M.; Zuhlke L.J.; Abbasi-Kangevari M.; Abdi A.; Abedi A.; Aboyans V.; Abrha W.A.; Abu-Gharbieh E.; Abushouk A.I.; Acharya D.; Adair T.; Adebayo O.M.; Ademi Z.; Advani S.M.; Afshari K.; Afshin A.; Agarwal G.; Agasthi P.; Ahmad S.; Ahmadi S.; Ahmed M.B.; Aji B.; Akalu Y.; Akande-Sholabi W.; Aklilu A.; Akunna C.J.; Alahdab F.; Al-Eyadhy A.; Alhabib K.F.; Alif S.M.; Alipour V.; Aljunid S.M.; Alla F.; Almasi-Hashiani A.; Almustanyir S.; Al-Raddadi R.M.; Amegah A.K.; Amini S.; Aminorroaya A.; Amu H.; Amugsi D.A.; Ancuceanu R.; Anderlini D.; Andrei T.; Andrei C.L.; Ansari-Moghaddam A.; Anteneh Z.A.; Antonazzo I.C.; Antony B.; Anwer R.; Appiah L.T.; Arabloo J.; &#xC4;rnl&#xF6;v J.; Artanti K.D.; Ataro Z.; Ausloos M.; Avila-Burgos L.; Awan A.T.; Awoke M.A.; Ayele H.T.; Ayza M.A.; Azari S.; B, D.B.; Baheiraei, N.; Baig, A.A.; Bakhtiari, A.; Banach, M.; Banik, P.C.; Baptista, E.A.; Barboza, M.A.; Barua, L.; Basu, S.; Bedi, N.; B&#xE9;jot, Y.; Bennett, D.A.; Bensenor, I.M.; Berman, A.E.; Bezabih, Y.M.; Bhagavathula, A.S.; Bhaskar, S.; Bhattacharyya, K.; Bijani, A.; Bikbov, B.; Birhanu, M.M.; Boloor, A.; Brant, L.C.; Brenner, H.; Briko, N.I.; Butt, Z.A.; Caetano dos Santos, F.L.; Cahill, L.E.; Cahuana-Hurtado, L.; C&#xE1;mera, L.A.; Campos-Nonato, I.R.; Cantu-Brito, C.; Car, J.; Carrero, J.J.; Carvalho, F.; Casta&#xF1;eda-Orjuela, C.A.; Catal&#xE1;-L&#xF3;pez, F.; Cerin, E.; Charan, J.; Chattu, V.K.; Chen, S.; Chin, K.L.; Choi, J-Y.J.; Chu, D-T.; Chung, S-C.; Cirillo, M.; Coffey, S.; Conti, S.; Costa, V.M.; Cundiff, D.K.; Dadras, O.; Dagnew, B.; Dai, X.; Damasceno, A.A.M.; Dandona, L.; Dandona, R.; Davletov, K.; De la Cruz-G&#xF3;ngora, V.; De la Hoz, F.P.; De Neve, J-W.; Denova-Guti&#xE9;rrez, E.; Derbew Molla, M.; Derseh, B.T.; Desai, R.; Deuschl, G.; Dharmaratne, S.D.; Dhimal, M.; Dhungana, R.R.; Dianatinasab, M.; Diaz, D.; Djalalinia, S.; Dokova, K.; Douiri, A.; Duncan, B.B.; Duraes, A.R.; Eagan, A.W.; Ebtehaj, S.; Eftekhari, A.; Eftekharzadeh, S.; Ekholuenetale, M.; El Nahas, N.; Elgendy, I.Y.; Elhadi, M.; El-Jaafary, S.I.; Esteghamati, S.; Etisso, A.E.; Eyawo, O.; Fadhil, I.; Faraon, E.J.A.; Faris, P.S.; Farwati, M.; Farzadfar, F.; Fernandes, E.; Fernandez Prendes, C.; Ferrara, P.; Filip, I.; Fischer, F.; Flood, D.; Fukumoto, T.; Gad, M.M.; Gaidhane, S.; Ganji, M.; Garg, J.; Gebre, A.K.; Gebregiorgis, B.G.; Gebregzabiher, K.Z.; Gebremeskel, G.G.; Getacher, L.; Obsa, A.G.; Ghajar, A.; Ghashghaee, A.; Ghith, N.; Giampaoli, S.; Gilani, S.A.; Gill, P.S.; Gillum, R.F.; Glushkova, E.V.; Gnedovskaya, E.V.; Golechha, M.; Gonfa, K.B.; Goudarzian, A.H.; Goulart, A.C.; Guadamuz, J.S.; Guha, A.; Guo, Y.; Gupta, R.; Hachinski, V.; Hafezi-Nejad, N.; Haile, T.G.; Hamadeh, R.R.; Hamidi, S.; Hankey, G.J.; Hargono, A.; Hartono, R.K.; Hashemian, M.; Hashi, A.; Hassan, S.; Hassen, H.Y.; Havmoeller, R.J.; Hay, S.I.; Hayat, K.; Heidari, G.; Herteliu, C.; Holla, R.; Hosseini, M.; Hosseinzadeh, M.; Hostiuc, M.; Hostiuc, S.; Househ, M.; Huang, J.; Humayun, A.; Iavicoli, I.; Ibeneme, C.U.; Ibitoye, S.E.; Ilesanmi, O.S.; Ilic, I.M.; Ilic, M.D.; Iqbal, U.; Irvani, S.S.N.; Islam, S.M.S.; Islam, R.M.; Iso, H.; Iwagami, M.; Jain, V.; Javaheri, T.; Jayapal, S.K.; Jayaram, S.; Jayawardena, R.; Jeemon, P.; Jha, R.P.; Jonas, J.B.; Jonnagaddala, J.; Joukar, F.; Jozwiak, J.J.; J&#xFC;risson, M.; Kabir, A.; Kahlon, T.; Kalani, R.; Kalhor, R.; Kamath, A.; Kamel, I.; Kandel, H.; Kandel, A.; Karch, A.; Kasa, A.S.; Katoto, P.D.M.C.; Kayode, G.A.; Khader, Y.S.; Khammarnia, M.; Khan, M.S.; Khan, M.N.; Khan, M.; Khan, E.A.; Khatab, K.; Kibria, G.M.A.; Kim, Y.J.; Kim, G.R.; Kimokoti, R.W.; Kisa, S.; Kisa, A.; Kivim&#xE4;ki, M.; Kolte, D.; Koolivand, A.; Korshunov, V.A.; Koulmane Laxminarayana, S.L.; Koyanagi, A.; Krishan, K.; Krishnamoorthy, V.; Kuate Defo, B.; Kucuk Bicer, B.; Kulkarni, V.; Kumar, G.A.; Kumar, N.; Kurmi, O.P.; Kusuma, D.; Kwan, G.F.; La Vecchia, C.; Lacey, B.; Lallukka, T.; Lan, Q.; Lasrado, S.; Lassi, Z.S.; Lauriola, P.; Lawrence, W.R.; Laxmaiah, A.; LeGrand, K.E.; Li, M-C.; Li, B.; Li, S.; Lim, S.S.; Lim, L-L.; Lin, H.; Lin, Z.; Lin, R-T.; Liu, X.; Lopez, A.D.; Lorkowski, S.; Lotufo, P.A.; Lugo, A.; M, N.K.; Madotto, F.; Mahmoudi, M.; Majeed, A.; Malekzadeh, R.; Malik, A.A.; Mamun, A.A.; Manafi, N.; Mansournia, M.A.; Mantovani, L.G.; Martini, S.; Mathur, M.R.; Mazzaglia, G.; Mehata, S.; Mehndiratta, M.M.; Meier, T.; Menezes, R.G.; Meretoja, A.; Mestrovic, T.; Miazgowski, B.; Miazgowski, T.; Michalek, I.M.; Miller, T.R.; Mirrakhimov, E.M.; Mirzaei, H.; Moazen, B.; Moghadaszadeh, M.; Mohammad, Y.; Mohammad, D.K.; Mohammed, S.; Mohammed, M.A.; Mokhayeri, Y.; Molokhia, M.; Montasir, A.A.; Moradi, G.; Moradzadeh, R.; Moraga, P.; Morawska, L.; Moreno Vel&#xE1;squez, I.; Morze, J.; Mubarik, S.; Muruet, W.; Musa, K.I.; Nagarajan, A.J.; Nalini, M.; Nangia, V.; Naqvi, A.A.; Narasimha Swamy, S.; Nascimento, B.R.; Nayak, V.C.; Nazari, J.; Nazarzadeh, M.; Negoi, R.I.; Neupane Kandel, S.; Nguyen, H.L.T.; Nixon, M.R.; Norrving, B.; Noubiap, J.J.; Nouthe, B.E.; Nowak, C.; Odukoya, O.O.; Ogbo, F.A.; Olagunju, A.T.; Orru, H.; Ortiz, A.; Ostroff, S.M.; Padubidri, J.R.; Palladino, R.; Pana, A.; Panda-Jonas, S.; Parekh, U.; Park, E-C.; Parvizi, M.; Pashazadeh Kan, F.; Patel, U.K.; Pathak, M.; Paudel, R.; Pepito, V.C.F.; Perianayagam, A.; Perico, N.; Pham, H.Q.; Pilgrim, T.; Piradov, M.A.; Pishgar, F.; Podder, V.; Polibin, R.V.; Pourshams, A.; Pribadi, D.R.A.; Rabiee, N.; Rabiee, M.; Radfar, A.; Rafiei, A.; Rahim, F.; Rahimi-Movaghar, V.; Ur Rahman, M.H.; Rahman, M.A.; Rahmani, A.M.; Rakovac, I.; Ram, P.; Ramalingam, S.; Rana, J.; Ranasinghe, P.; Rao, S.J.; Rathi, P.; Rawal, L.; Rawasia, W.F.; Rawassizadeh, R.; Remuzzi, G.; Renzaho, A.M.N.; Rezapour, A.; Riahi, S.M.; Roberts-Thomson, R.L.; Roever, L.; Rohloff, P.; Romoli, M.; Roshandel, G.; Rwegerera, G.M.; Saadatagah, S.; Saber-Ayad, M.M.; Sabour, S.; Sacco, S.; Sadeghi, M.; Saeedi Moghaddam, S.; Safari, S.; Sahebkar, A.; Salehi, S.; Salimzadeh, H.; Samaei, M.; Samy, A.M.; Santos, I.S.; Santric-Milicevic, M.M.; Sarrafzadegan, N.; Sarveazad, A.; Sathish, T.; Sawhney, M.; Saylan, M.; Schmidt, M.I.; Schutte, A.E.; Senthilkumaran, S.; Sepanlou, S.G.; Sha, F.; Shahabi, S.; Shahid, I.; Shaikh, M.A.; Shamali, M.; Shamsizadeh, M.; Shawon, M.S.R.; Sheikh, A.; Shigematsu, M.; Shin, M-J.; Shin, J.I.; Shiri, R.; Shiue, I.; Shuval, K.; Siabani, S.; Siddiqi, T.J.; Silva, D.A.S.; Singh, J.A.; Mtech, A.S.; Skryabin, V.Y.; Skryabina, A.A.; Soheili, A.; Spurlock, E.E.; Stockfelt, L.; Stortecky, S.; Stranges, S.; Suliankatchi Abdulkader, R.; Tadbiri, H.; Tadesse, E.G.; Tadesse, D.B.; Tajdini, M.; Tariqujjaman, M.; Teklehaimanot, B.F.; Temsah, M-H.; Tesema, A.K.; Thakur, B.; Thankappan, K.R.; Thapar, R.; Thrift, A.G.; Timalsina, B.; Tonelli, M.; Touvier, M.; Tovani-Palone, M.R.; Tripathi, A.; Tripathy, J.P.; Truelsen, T.C.; Tsegay, G.M.; Tsegaye, G.W.; Tsilimparis, N.; Tusa, B.S.; Tyrovolas, S.; Umapathi, K.K.; Unim, B.; Unnikrishnan, B.; Usman, M.S.; Vaduganathan, M.; Valdez, P.R.; Vasankari, T.J.; Velazquez, D.Z.; Venketasubramanian, N.; Vu, G.T.; Vujcic, I.S.; Waheed, Y.; Wang, Y.; Wang, F.; Wei, J.; Weintraub, R.G.; Weldemariam, A.H.; Westerman, R.; Winkler, A.S.; Wiysonge, C.S.; Wolfe, C.D.A.; Wubishet, B.L.; Xu, G.; Yadollahpour, A.; Yamagishi, K.; Yan, L.L.; Yandrapalli, S.; Yano, Y.; Yatsuya, H.; Yeheyis, T.Y.; Yeshaw, Y.; Yilgwan, C.S.; Yonemoto, N.; Yu, C.; Yusefzadeh, H.; Zachariah, G.; Zaman, S.B.; Zaman, M.S.; Zamanian, M.; Zand, R.; Zandifar, A.; Zarghi, A.; Zastrozhin, M.S.; Zastrozhina, A.; Zhang, Z-J.; Zhang, Y.; Zhang, W.; Zhong, C.; Zou, Z.; Zuniga, Y.M.H.; Murray, C.J.L.; Fuster, V. Global burden of cardiovascular diseases and risk factors, 1990-2019. J Am Coll Cardiol 2020,76(25),2982-3021","journal-title":"J Am Coll Cardiol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/ehjqcco\/qcaa076","volume":"8","author":"Dai H.","year":"2022","unstructured":"Dai H.; Much A.A.; Maor E.; Asher E.; Younis A.; Xu Y.; Lu Y.; Liu X.; Shu J.; Bragazzi N.L.; Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990-2017: Results from the Global Burden of Disease Study 2017. Eur Heart J Qual Care Clin Outcomes 2022,8(1),50-60","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"Knuuti J.","year":"2020","unstructured":"Knuuti J.; Wijns W.; Saraste A.; Capodanno D.; Barbato E.; Funck-Brentano C.; Prescott E.; Storey R.F.; Deaton C.; Cuisset T.; Agewall S.; Dickstein K.; Edvardsen T.; Escaned J.; Gersh B.J.; Svitil P.; Gilard M.; Hasdai D.; Hatala R.; Mahfoud F.; Masip J.; Muneretto C.; Valgimigli M.; Achenbach S.; Bax J.J.; Neumann F-J.; Sechtem U.; Banning A.P.; Bonaros N.; Bueno H.; Bugiardini R.; Chieffo A.; Crea F.; Czerny M.; Delgado V.; Dendale P.; Flachskampf F.A.; Gohlke H.; Grove E.L.; James S.; Katritsis D.; Landmesser U.; Lettino M.; Matter C.M.; Nathoe H.; Niessner A.; Patrono C.; Petronio A.S.; Pettersen S.E.; Piccolo R.; Piepoli M.F.; Popescu B.A.; R&#xE4;ber L.; Richter D.J.; Roffi M.; Roithinger F.X.; Shlyakhto E.; Sibbing D.; Silber S.; Simpson I.A.; Sousa-Uva M.; Vardas P.; Witkowski A.; Zamorano J.L.; Achenbach S.; Agewall S.; Barbato E.; Bax J.J.; Capodanno D.; Cuisset T.; Deaton C.; Dickstein K.; Edvardsen T.; Escaned J.; Funck-Brentano C.; Gersh B.J.; Gilard M.; Hasdai D.; Hatala R.; Mahfoud F.; Masip J.; Muneretto C.; Prescott E.; Saraste A.; Storey R.F.; Svitil P.; Valgimigli M.; Windecker S.; Aboyans V.; Baigent C.; Collet J-P.; Dean V.; Delgado V.; Fitzsimons D.; Gale C.P.; Grobbee D.; Halvorsen S.; Hindricks G.; Iung B.; J&#xFC;ni P.; Katus H.A.; Landmesser U.; Leclercq C.; Lettino M.; Lewis B.S.; Merkely B.; Mueller C.; Petersen S.; Petronio A.S.; Richter D.J.; Roffi M.; Shlyakhto E.; Simpson I.A.; Sousa-Uva M.; Touyz R.M.; Benkhedda S.; Metzler B.; Sujayeva V.; Cosyns B.; Kusljugic Z.; Velchev V.; Panayi G.; Kala P.; Haahr-Pedersen S.A.; Kabil H.; Ainla T.; Kaukonen T.; Cayla G.; Pagava Z.; Woehrle J.; Kanakakis J.; T&#xF3;th K.; Gudnason T.; Peace A.; Aronson D.; Riccio C.; Elezi S.; Mirrakhimov E.; Hansone S.; Sarkis A.; Babarskiene R.; Beissel J.; Maempel A.J.C.; Revenco V.; de Grooth G.J.; Pejkov H.; Julieb&#xF8; V.; Lipiec P.; Santos J.; Chioncel O.; Duplyakov D.; Bertelli L.; Dikic A.D.; Studen&#x10D;an, M.; Bunc, M.; Alfonso, F.; B&#xE4;ck, M.; Zellweger, M.; Addad, F.; Yildirir, A.; Sirenko, Y.; Clapp, B. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020,41(3),407-477","journal-title":"Eur Heart J"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/CRD.0b013e31828c5ced","volume":"21","author":"Chistiakov D.A.","year":"2013","unstructured":"Chistiakov D.A.; Sobenin I.A.; Orekhov A.N.; Vascular extracellular matrix in atherosclerosis. Cardiol Rev 2013,21(6),270-288","journal-title":"Cardiol Rev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1161\/ATVBAHA.108.179697","volume":"30","author":"Steinberg D.","year":"2010","unstructured":"Steinberg D.; Witztum J.L.; Oxidized low-density lipoprotein and atherosclerosis. Arterioscler Thromb Vasc Biol 2010,30(12),2311-2316","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","volume":"118","author":"Gimbrone M.A.","year":"2016","unstructured":"Gimbrone M.A.; Garc&#xED;a-Carde&#xF1;a G.; Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res 2016,118(4),620-636","journal-title":"Circ Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3390\/biomedicines9070781","volume":"9","author":"Theofilis P.","year":"2021","unstructured":"Theofilis P.; Sagris M.; Oikonomou E.; Antonopoulos A.S.; Siasos G.; Tsioufis C.; Tousoulis D.; Inflammatory mechanisms contributing to endothelial dysfunction. Biomedicines 2021,9(7),781","journal-title":"Biomedicines"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"6607","DOI":"10.3390\/ijms22126607","volume":"22","author":"Sagris M.","year":"2021","unstructured":"Sagris M.; Theofilis P.; Antonopoulos A.S.; Tsioufis C.; Oikonomou E.; Antoniades C.; Crea F.; Kaski J.C.; Tousoulis D.; Inflammatory mechanisms in COVID-19 and atherosclerosis: Current pharmaceutical perspectives. Int J Mol Sci 2021,22(12),6607","journal-title":"Int J Mol Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/ATVBAHA.117.309228","volume":"37","author":"Nowak W.N.","year":"2017","unstructured":"Nowak W.N.; Deng J.; Ruan X.Z.; Xu Q.; Reactive oxygen species generation and atherosclerosis. Arterioscler Thromb Vasc Biol 2017,37(5),e41-e52","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.atherosclerosis.2020.07.027","volume":"309","author":"Oikonomou E.","year":"2020","unstructured":"Oikonomou E.; Leopoulou M.; Theofilis P.; Antonopoulos A.S.; Siasos G.; Latsios G.; Mystakidi V.C.; Antoniades C.; Tousoulis D.; A link between inflammation and thrombosis in atherosclerotic cardiovascular diseases: Clinical and therapeutic implications. Atherosclerosis 2020,309,16-26","journal-title":"Atherosclerosis"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1161\/CIRCULATIONAHA.120.049922","volume":"143","author":"Miano J.M.","year":"2021","unstructured":"Miano J.M.; Fisher E.A.; Majesky M.W.; Fate and state of vascular smooth muscle cells in atherosclerosis. Circulation 2021,143(21),2110-2116","journal-title":"Circulation"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/cvr\/cvs115","volume":"95","author":"Gomez D.","year":"2012","unstructured":"Gomez D.; Owens G.K.; Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res 2012,95(2),156-164","journal-title":"Cardiovasc Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nm.3866","volume":"21","author":"Shankman L.S.","year":"2015","unstructured":"Shankman L.S.; Gomez D.; Cherepanova O.A.; Salmon M.; Alencar G.F.; Haskins R.M.; Swiatlowska P.; Newman A.A.C.; Greene E.S.; Straub A.C.; Isakson B.; Randolph G.J.; Owens G.K.; KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat Med 2015,21(6),628-637","journal-title":"Nat Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00001573-200109000-00006","volume":"16","author":"Kolodgie F.D.","year":"2001","unstructured":"Kolodgie F.D.; Burke A.P.; Farb A.; Gold H.K.; Yuan J.; Narula J.; Finn A.V.; Virmani R.; The thin-cap fibroatheroma: A type of vulnerable plaque: The major precursor lesion to acute coronary syndromes. Curr Opin Cardiol 2001,16(5),285-292","journal-title":"Curr Opin Cardiol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000446703","volume":"53","author":"Ruddy J.M.","year":"2016","unstructured":"Ruddy J.M.; Ikonomidis J.S.; Jones J.A.; Multidimensional contribution of matrix metalloproteinases to atherosclerotic plaque vulnerability: Multiple mechanisms of inhibition to promote stability. J Vasc Res 2016,53(1-2),1-16","journal-title":"J Vasc Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.pcad.2009.12.002","volume":"52","author":"B&#xE4;ck M.","year":"2010","unstructured":"B&#xE4;ck M.; Ketelhuth D.F.J.; Agewall S.; Matrix metalloproteinases in atherothrombosis. Prog Cardiovasc Dis 2010,52(5),410-428","journal-title":"Prog Cardiovasc Dis"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"928315","DOI":"10.1155\/2013\/928315","volume":"2013","author":"Chen Q.","year":"2013","unstructured":"Chen Q.; Jin M.; Yang F.; Zhu J.; Xiao Q.; Zhang L.; Matrix metalloproteinases: Inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediators Inflamm 2013,2013,928315","journal-title":"Mediators Inflamm"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2741\/1810","volume":"11","author":"Brauer P.R.","year":"2006","unstructured":"Brauer P.R.; MMPs-role in cardiovascular development and disease. Front Biosci 2006,11(1),447-478","journal-title":"Front Biosci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/clc.4960260203","volume":"26","author":"Ikeda U.","year":"2003","unstructured":"Ikeda U.; Shimada K.; Matrix metalloproteinases and coronary artery diseases. Clin Cardiol 2003,26(2),55-59","journal-title":"Clin Cardiol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1161\/01.ATV.0000239461.87113.0b","volume":"26","author":"Choudhary S.","year":"2006","unstructured":"Choudhary S.; Higgins C.L.; Chen I.Y.; Reardon M.; Lawrie G.; Vick G.W.; Karmonik C.; Via D.P.; Morrisett J.D.; Quantitation and localization of matrix metalloproteinases and their inhibitors in human carotid endarterectomy tissues. Arterioscler Thromb Vasc Biol 2006,26(10),2351-2358","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1172\/JCI67526","volume":"123","author":"Libby P.","year":"2013","unstructured":"Libby P.; Collagenases and cracks in the plaque. J Clin Invest 2013,123(8),3201-3203","journal-title":"J Clin Invest"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1749-6632.1994.tb17348.x","volume":"748","author":"Galis Z.S.","year":"1994","unstructured":"Galis Z.S.; Muszynski M.; Sukhova G.K.; Simon-Morrissey E.; Libby P.; Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann N Y Acad Sci 1994,748(1),501-507","journal-title":"Ann N Y Acad Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"19158","DOI":"10.1074\/jbc.M114.634022","volume":"290","author":"Wen G.","year":"2015","unstructured":"Wen G.; Zhang C.; Chen Q.; Luong L.A.; Mustafa A.; Ye S.; Xiao Q.; A novel role of matrix metalloproteinase-8 in macrophage differentiation and polarization. J Biol Chem 2015,290(31),19158-19172","journal-title":"J Biol Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2174\/1389450115666140211115805","volume":"15","author":"Lin J.","year":"2014","unstructured":"Lin J.; Kakkar V.; Lu X.; Impact of matrix metalloproteinases on atherosclerosis. Curr Drug Targets 2014,15(4),442-453","journal-title":"Curr Drug Targets"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0955-0674(96)80061-5","volume":"8","author":"Spiegel S.","year":"1996","unstructured":"Spiegel S.; Foster D.; Kolesnick R.; Signal transduction through lipid second messengers. Curr Opin Cell Biol 1996,8(2),159-167","journal-title":"Curr Opin Cell Biol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1097\/HJH.0b013e3283614c1c","volume":"31","author":"Morillas P.","year":"2013","unstructured":"Morillas P.; Quiles J.; de Andrade H.; Castillo J.; Taraz&#xF3;n E.; Rosell&#xF3; E.; Portol&#xE9;s M.; Rivera M.; Bertomeu-Mart&#xED;nez V.; Circulating biomarkers of collagen metabolism in arterial hypertension. J Hypertens 2013,31(8),1611-1617","journal-title":"J Hypertens"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/bioengineering9030119","volume":"9","author":"Kostov K.","year":"2022","unstructured":"Kostov K.; Blazhev A.; Changes in serum levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in patients with essential hypertension. Bioengineering 2022,9(3),119","journal-title":"Bioengineering"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"20052","DOI":"10.1038\/s41598-021-99577-2","volume":"11","author":"Boumiza S.","year":"2021","unstructured":"Boumiza S.; Chahed K.; Tabka Z.; Jacob M.P.; Norel X.; Ozen G.; MMPs and TIMPs levels are correlated with anthropometric parameters, blood pressure, and endothelial function in obesity. Sci Rep 2021,11(1),20052","journal-title":"Sci Rep"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2174\/1874192401105010110","volume":"5","author":"Tanindi A.","year":"2011","unstructured":"Tanindi A.; Sahinarslan A.; Elbeg S.; Cemri M.; Relationship between MMP-1, MMP-9, TIMP-1, IL-6 and risk factors, clinical presentation, extent and severity of atherosclerotic coronary artery disease. Open Cardiovasc Med J 2011,5(1),110-116","journal-title":"Open Cardiovasc Med J"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3390\/jpm11060506","volume":"11","author":"Polonskaya Y.V.","year":"2021","unstructured":"Polonskaya Y.V.; Kashtanova E.V.; Murashov I.S.; Striukova E.V.; Kurguzov A.V.; Stakhneva E.M.; Shramko V.S.; Maslatsov N.A.; Chernyavsky A.M.; Ragino Y.I.; Association of matrix metalloproteinases with coronary artery calcification in patients with CHD. J Pers Med 2021,11(6),506","journal-title":"J Pers Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1475-2840-8-50","volume":"8","author":"Lehrke M.","year":"2009","unstructured":"Lehrke M.; Greif M.; Broedl U.C.; Lebherz C.; Laubender R.P.; Becker A.; von Ziegler F.; Tittus J.; Reiser M.; Becker C.; G&#xF6;ke B.; Steinbeck G.; Leber A.W.; Parhofer K.G.; MMP-1 serum levels predict coronary atherosclerosis in humans. Cardiovasc Diabetol 2009,8(1),50","journal-title":"Cardiovasc Diabetol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/bs.pmbts.2017.02.002","volume":"147","author":"Rabkin S.W.","year":"2017","unstructured":"Rabkin S.W.; The role matrix metalloproteinases in the production of aortic aneurysm. Prog Mol Biol Transl Sci 2017,147,239-265","journal-title":"Prog Mol Biol Transl Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"e22174","DOI":"10.1002\/jcla.22174","volume":"32","author":"Bayoglu B.","year":"2018","unstructured":"Bayoglu B.; Arslan C.; Tel C.; Ulutin T.; Dirican A.; Deser S.B.; Cengiz M.; Genetic variants rs1994016 and rs3825807 in ADAMTS7 affect its mRNA expression in atherosclerotic occlusive peripheral arterial disease. J Clin Lab Anal 2018,32(1),e22174","journal-title":"J Clin Lab Anal"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.cca.2009.02.013","volume":"403","author":"Gon&#xE7;alves F.M.","year":"2009","unstructured":"Gon&#xE7;alves F.M.; Jacob-Ferreira A.L.B.; Gomes V.A.; Casella-Filho A.; Chagas A.C.P.; Marcaccini A.M.; Gerlach R.F.; Tanus-Santos J.E.; Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome. Clin Chim Acta 2009,403(1-2),173-177","journal-title":"Clin Chim Acta"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1253\/circj.69.1035","volume":"69","author":"Kato R.","year":"2005","unstructured":"Kato R.; Momiyama Y.; Ohmori R.; Taniguchi H.; Nakamura H.; Ohsuzu F.; Plasma matrix metalloproteinase-8 concentrations are associated with the presence and severity of coronary artery disease. Circ J 2005,69(9),1035-1040","journal-title":"Circ J"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"951","DOI":"10.7754\/Clin.Lab.2013.130346","volume":"60","author":"Allal-Elasmi M.","year":"2014","unstructured":"Allal-Elasmi M.; Zayani Y.; Zidi W.; Zaroui A.; Feki M.; Mourali S.; Mechmeche R.; Kaabachi N.; The measurement of circulating matrix metalloproteinase-8 and its tissue inhibitor and their association with inflammatory mediators in patients with acute coronary syndrome. Clin Lab 2014,60(06\/2014),951-956","journal-title":"Clin Lab"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.atherosclerosis.2009.07.037","volume":"209","author":"Momiyama Y.","year":"2010","unstructured":"Momiyama Y.; Ohmori R.; Tanaka N.; Kato R.; Taniguchi H.; Adachi T.; Nakamura H.; Ohsuzu F.; High plasma levels of matrix metalloproteinase-8 in patients with unstable angina. Atherosclerosis 2010,209(1),206-210","journal-title":"Atherosclerosis"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1177\/2047487312465524","volume":"21","author":"Tuomainen A.M.","year":"2014","unstructured":"Tuomainen A.M.; Kormi I.; Havulinna A.S.; Tervahartiala T.; Salomaa V.; Sorsa T.; Pussinen P.J.; Serum tissue-degrading proteinases and incident cardiovascular disease events. Eur J Prev Cardiol 2014,21(7),806-812","journal-title":"Eur J Prev Cardiol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"e71280","DOI":"10.1371\/journal.pone.0071280","volume":"8","author":"Fertin M.","year":"2013","unstructured":"Fertin M.; Lemesle G.; Turkieh A.; Beseme O.; Chwastyniak M.; Amouyel P.; Bauters C.; Pinet F.; Serum MMP-8: A novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarction. PLoS One 2013,8(8),e71280","journal-title":"PLoS One"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1007\/s11033-019-04914-4","volume":"46","author":"Guizani I.","year":"2019","unstructured":"Guizani I.; Zidi W.; Zayani Y.; Boudiche S.; Hadj-Taieb S.; Sanhaji H.; Zaroui A.; Mechmeche R.; Mourali M.S.; Feki M.; Allal-Elasmi M.; Matrix metalloproteinase-3 predicts clinical cardiovascular outcomes in patients with coronary artery disease: A 5 years cohort study. Mol Biol Rep 2019,46(5),4699-4707","journal-title":"Mol Biol Rep"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.jacc.2019.06.077","volume":"74","author":"Lau E.S.","year":"2019","unstructured":"Lau E.S.; Paniagua S.M.; Guseh J.S.; Bhambhani V.; Zanni M.V.; Courchesne P.; Lyass A.; Larson M.G.; Levy D.; Ho J.E.; Sex differences in circulating biomarkers of cardiovascular disease. J Am Coll Cardiol 2019,74(12),1543-1553","journal-title":"J Am Coll Cardiol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"e001731","DOI":"10.1161\/CIRCGENETICS.117.001731","volume":"10","author":"Salminen A.","year":"2017","unstructured":"Salminen A.; Vlachopoulou E.; Havulinna A.S.; Tervahartiala T.; Sattler W.; Lokki M.L.; Nieminen M.S.; Perola M.; Salomaa V.; Sinisalo J.; Meri S.; Sorsa T.; Pussinen P.J.; Genetic variants contributing to circulating matrix metalloproteinase 8 levels and their association with cardiovascular diseases. Circ Cardiovasc Genet 2017,10(6),e001731","journal-title":"Circ Cardiovasc Genet"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1365-2362.2007.01919.x","volume":"38","author":"Suzuki H.","year":"2008","unstructured":"Suzuki H.; Kusuyama T.; Sato R.; Yokota Y.; Tsunoda F.; Sato T.; Shoji M.; Iso Y.; Koba S.; Katagiri T.; Elevation of matrix metalloproteinases and interleukin-6 in the culprit coronary artery of myocardial infarction. Eur J Clin Invest 2008,38(3),166-173","journal-title":"Eur J Clin Invest"},{"key":"ref=44","first-page":"70","author":"Minukhina D.","year":"2020","unstructured":"Minukhina D.; Zaikina T.; Koteliukh M.; Titova G.; Zolotaikina V.; Impact of percutaneous coronary intervention on markers of matrix degradation and endothelial-dependent mediators in patients with acute myocardial infarction and diabetes mellitus type 2. Georgian Med News 2020(299),70-74","journal-title":"Georgian Med News"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1155\/2012\/795739","volume":"33","year":"2012","unstructured":"Va\u0161k&#x16F; A.; Meluz&#xED;n, J.; Blah&#xE1;k, J.; Kincl, V.; P&#xE1;vkov&#xE1; Goldbergov&#xE1;, M.; Sitar, J.; Zl&#xE1;mal, F.; Bienertov&#xE1;-Va\u0161k&#x16F; J.; V&#xED;tovec, J. Matrix metalloproteinase 13 genotype in rs640198 polymorphism is associated with severe coronary artery disease. Dis Markers 2012,33(1),43-49","journal-title":"Dis Markers"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1161\/01.RES.75.1.181","volume":"75","author":"Galis Z.S.","year":"1994","unstructured":"Galis Z.S.; Muszynski M.; Sukhova G.K.; Simon-Morrissey E.; Unemori E.N.; Lark M.W.; Amento E.; Libby P.; Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 1994,75(1),181-189","journal-title":"Circ Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1042\/bj2960803","volume":"296","author":"Hanemaaijer R.","year":"1993","unstructured":"Hanemaaijer R.; Koolwijk P.; le Clercq L.; de Vree W.J.A.; van Hinsbergh V.W.M.; Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor &#x3B1; interleukin 1 and phorbol ester. Biochem J 1993,296(3),803-809","journal-title":"Biochem J"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1161\/01.CIR.91.8.2125","volume":"91","author":"Brown D.L.","year":"1995","unstructured":"Brown D.L.; Hibbs M.S.; Kearney M.; Loushin C.; Isner J.M.; Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation 1995,91(8),2125-2131","journal-title":"Circulation"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.3892\/etm.2018.6424","volume":"16","author":"Guo Z.Y.","year":"2018","unstructured":"Guo Z.Y.; Zhang B.; Yan Y.H.; Gao S.S.; Liu J.J.; Xu L.; Hui P.J.; Specific matrix metalloproteinases and calcification factors are associated with the vulnerability of human carotid plaque. Exp Ther Med 2018,16(3),2071-2079","journal-title":"Exp Ther Med"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.nucmedbio.2014.04.085","volume":"41","author":"M&#xFC;ller A.","year":"2014","unstructured":"M&#xFC;ller A.; Kr&#xE4;mer S.D.; Meletta R.; Beck K.; Selivanova S.V.; Rancic Z.; Kaufmann P.A.; Vos B.; Meding J.; Stellfeld T.; Heinrich T.K.; Bauser M.; H&#xFC;tter J.; Dinkelborg L.M.; Schibli R.; Ametamey S.M.; Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability. Nucl Med Biol 2014,41(7),562-569","journal-title":"Nucl Med Biol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12933-017-0539-1","volume":"16","author":"Peeters S.A.","year":"2017","unstructured":"Peeters S.A.; Engelen L.; Buijs J.; Jorsal A.; Parving H.H.; Tarnow L.; Rossing P.; Schalkwijk C.G.; Stehouwer C.D.A.; Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: A 12-year follow-up study. Cardiovasc Diabetol 2017,16(1),55","journal-title":"Cardiovasc Diabetol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"124","DOI":"10.25011\/cim.v32i2.6030","volume":"32","author":"Derosa G.","year":"2009","unstructured":"Derosa G.; Maffioli P.; D\u2019Angelo A.; Salvadeo S.A.T.; Ferrari I.; Fogari E.; Gravina A.; Mereu R.; Palumbo I.; Randazzo S.; Cicero A.F.G.; Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia. Clin Invest Med 2009,32(2),124","journal-title":"Clin Invest Med"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/10623320802228815","volume":"15","author":"Derosa G.","year":"2008","unstructured":"Derosa G.; Ferrari I.; D\u2019Angelo A.; Tinelli C.; Salvadeo S.A.T.; Ciccarelli L.; Piccinni M.N.; Gravina A.; Ramondetti F.; Maffioli P.; Cicero A.F.G.; Matrix metalloproteinase-2 and -9 levels in obese patients. Endothelium 2008,15(4),219-224","journal-title":"Endothelium"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13098-015-0108-2","volume":"7","author":"Yu A.P.","year":"2015","unstructured":"Yu A.P.; Tam B.T.; Yau W.Y.; Chan K.S.; Yu S.S.; Chung T.L.; Siu P.M.; Association of endothelin-1 and matrix metallopeptidase-9 with metabolic syndrome in middle-aged and older adults. Diabetol Metab Syndr 2015,7(1),111","journal-title":"Diabetol Metab Syndr"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/biom9040129","volume":"9","author":"Ezhov M.","year":"2019","unstructured":"Ezhov M.; Safarova M.; Afanasieva O.; Mitroshkin M.; Matchin Y.; Pokrovsky S.; Matrix metalloproteinase 9 as a predictor of coronary atherosclerotic plaque instability in stable coronary heart disease patients with elevated lipoprotein(a) levels. Biomolecules 2019,9(4),129","journal-title":"Biomolecules"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0735-1097(98)00250-2","volume":"32","author":"Kai H.","year":"1998","unstructured":"Kai H.; Ikeda H.; Yasukawa H.; Kai M.; Seki Y.; Kuwahara F.; Ueno T.; Sugi K.; Imaizumi T.; Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 1998,32(2),368-372","journal-title":"J Am Coll Cardiol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1067\/mhj.2001.112238","volume":"141","author":"Inokubo Y.","year":"2001","unstructured":"Inokubo Y.; Hanada H.; Ishizaka H.; Fukushi T.; Kamada T.; Okumura K.; Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. Am Heart J 2001,141(2),211-217","journal-title":"Am Heart J"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"e0220841","DOI":"10.1371\/journal.pone.0220841","volume":"14","author":"Li C.","year":"2019","unstructured":"Li C.; Zhang Z.; Peng Y.; Gao H.; Wang Y.; Zhao J.; Pan C.; Plasma neutrophil gelatinase-associated lipocalin levels are associated with the presence and severity of coronary heart disease. PLoS One 2019,14(8),e0220841","journal-title":"PLoS One"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1040171","DOI":"10.1155\/2021\/1040171","volume":"2021","author":"Li Y.","year":"2021","unstructured":"Li Y.; Li L.; Wang K.; Wu P.; Cui Y.; Investigation on risk stratification and the prognostic value of hs-TnT combined with MMP-2 in patients with acute coronary syndrome. BioMed Res Int 2021,2021,1040171","journal-title":"BioMed Res Int"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12865-021-00406-y","volume":"22","author":"Li Y.","year":"2021","unstructured":"Li Y.; Qin L.; Bai Q.; Zhang J.; Chen R.; Song K.; CD100 modulates cytotoxicity of CD8+ T cells in patients with acute myocardial infarction. BMC Immunol 2021,22(1),13","journal-title":"BMC Immunol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1042\/CS20090226","volume":"118","author":"Dhillon O.S.","year":"2010","unstructured":"Dhillon O.S.; Khan S.Q.; Narayan H.K.; Ng K.H.; Mohammed N.; Quinn P.A.; Squire I.B.; Davies J.E.; Ng L.L.; Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndrome. Clin Sci 2010,118(4),249-257","journal-title":"Clin Sci"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1177\/1076029614567309","volume":"21","author":"Hamed G.M.","year":"2015","unstructured":"Hamed G.M.; Fattah M.F.A.; Clinical relevance of matrix metalloproteinase 9 in patients with acute coronary syndrome. Clin Appl Thromb Hemost 2015,21(8),705-711","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref=63","doi-asserted-by":"publisher","DOI":"10.1177\/00033197221098295","author":"Goliopoulou A.","year":"2022","unstructured":"Goliopoulou A.; Oikonomou E.; Antonopoulos A.; Koumallos N.; Gazouli M.; Theofilis P.; Mystakidi V.C.; Pantelidis P.; Vavuranakis M.A.; Siasos G.; Tousoulis D.; Expression of tissue microRNAs in ascending aortic aneurysms and dissections. Angiology [Epub ahead of print].2022","journal-title":"Angiology"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/j.1365-2796.2008.01927.x","volume":"263","author":"Olson F.J.","year":"2008","unstructured":"Olson F.J.; Schmidt C.; Gummesson A.; Sigurdardottir V.; Hulthe J.; Wiklund O.; Fagerberg B.; Circulating matrix metalloproteinase 9 levels in relation to sampling methods, femoral and carotid atherosclerosis. J Intern Med 2008,263(6),626-635","journal-title":"J Intern Med"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1191\/1358863x05vm582oa","volume":"10","author":"Signorelli S.S.","year":"2005","unstructured":"Signorelli S.S.; Malaponte G.; Libra M.; Pino L.D.; Celotta G.; Bevelacqua V.; Petrina M.; Nicotra G.S.; Indelicato M.; Navolanic P.M.; Pennisi G.; Mazzarino M.C.; Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease. Vasc Med 2005,10(1),1-6","journal-title":"Vasc Med"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"8154","DOI":"10.1073\/pnas.88.18.8154","volume":"88","author":"Henney A.M.","year":"1991","unstructured":"Henney A.M.; Wakeley P.R.; Davies M.J.; Foster K.; Hembry R.; Murphy G.; Humphries S.; Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci 1991,88(18),8154-8158","journal-title":"Proc Natl Acad Sci"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1161\/hq0901.097004","volume":"21","author":"Silence J.","year":"2001","unstructured":"Silence J.; Lupu F.; Collen D.; Lijnen H.R.; Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation. Arterioscler Thromb Vasc Biol 2001,21(9),1440-1445","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.2741\/2896","volume":"13","author":"Rodriguez J.A.","year":"2008","unstructured":"Rodriguez J.A.; Orbe J.; Martinez de Lizarrondo S.; Calvayrac O.; Rodriguez C.; Martinez-Gonzalez J.; Paramo J.A.; Metalloproteinases and atherothrombosis: MMP-10 mediates vascular remodeling promoted by inflammatory stimuli. Front Biosci 2008,13(13),2916-2921","journal-title":"Front Biosci"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"e003048","DOI":"10.1161\/JAHA.115.003048","volume":"5","author":"van der Leeuw J.","year":"2016","unstructured":"van der Leeuw J.; Beulens J.W.J.; van Dieren S.; Schalkwijk C.G.; Glatz J.F.C.; Hofker M.H.; Verschuren W.M.M.; Boer J.M.A.; van der Graaf Y.; Visseren F.L.J.; Peelen L.M.; van der Schouw Y.T.; Novel biomarkers to improve the prediction of cardiovascular event risk in type 2 diabetes mellitus. J Am Heart Assoc 2016,5(6),e003048","journal-title":"J Am Heart Assoc"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1365-2362.2005.01548.x","volume":"35","author":"Wu T.C.","year":"2005","unstructured":"Wu T.C.; Leu H.B.; Lin W.T.; Lin C.P.; Lin S.J.; Chen J.W.; Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease. Eur J Clin Invest 2005,35(9),537-545","journal-title":"Eur J Clin Invest"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejheart.2007.12.009","volume":"10","author":"Kelly D.","year":"2008","unstructured":"Kelly D.; Khan S.; Cockerill G.; Ng L.L.; Thompson M.; Samani N.J.; Squire I.B.; Circulating stromelysin-1 (MMP-3): A novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction. Eur J Heart Fail 2008,10(2),133-139","journal-title":"Eur J Heart Fail"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.amjcard.2015.12.022","volume":"117","author":"Cavusoglu E.","year":"2016","unstructured":"Cavusoglu E.; Marmur J.D.; Kassotis J.T.; Yanamadala S.; Chopra V.; Eng C.; Usefulness of plasma matrix metalloproteinase-3 levels to predict myocardial infarction in men with and without acute coronary syndrome. Am J Cardiol 2016,117(6),881-886","journal-title":"Am J Cardiol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.atherosclerosis.2010.05.040","volume":"212","author":"Lien L.M.","year":"2010","unstructured":"Lien L.M.; Hsieh Y.C.; Bai C.H.; Chen W.H.; Chiu H.C.; Hsieh F.I.; Shyu K.G.; Chiou H.Y.; Hsu C.Y.; Association of blood active matrix metalloproteinase-3 with carotid plaque score from a community population in Taiwan. Atherosclerosis 2010,212(2),595-600","journal-title":"Atherosclerosis"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1161\/hc0402.102621","volume":"105","author":"Carrell T.W.G.","year":"2002","unstructured":"Carrell T.W.G.; Burnand K.G.; Wells G.M.A.; Clements J.M.; Smith A.; Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 2002,105(4),477-482","journal-title":"Circulation"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0300-8932(08)75734-8","volume":"61","author":"P&#xE1;ramo J.A.","year":"2008","unstructured":"P&#xE1;ramo J.A.; Beloqui O.; Rodr&#xED;guez J.A.; Diez J.; Orbe J.; Association between matrix metalloproteinase-10 concentration and smoking in individuals without cardiovascular disease. Rev Esp Cardiol 2008,61(12),1267-1273","journal-title":"Rev Esp Cardiol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1538-7836.2006.02276.x","volume":"5","author":"Orbe J.","year":"2007","unstructured":"Orbe J.; Montero I.; Rodr&#xED;guez J.A.; Beloqui O.; Roncal C.; P&#xE1;ramo J.A.; Independent association of matrix metalloproteinase-10, cardiovascular risk factors and subclinical atherosclerosis. J Thromb Haemost 2007,5(1),91-97","journal-title":"J Thromb Haemost"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/ki.2010.329","volume":"78","author":"Coll B.","year":"2010","unstructured":"Coll B.; Rodr&#xED;guez J.A.; Craver L.; Orbe J.; Mart&#xED;nez-Alonso M.; Ortiz A.; D&#xED;ez J.; Beloqui O.; Borras M.; Valdivielso J.M.; Fern&#xE1;ndez E.; P&#xE1;ramo J.A.; Serum levels of matrix metalloproteinase-10 are associated with the severity of atherosclerosis in patients with chronic kidney disease. Kidney Int 2010,78(12),1275-1280","journal-title":"Kidney Int"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jvs.2014.09.002","volume":"61","author":"Martinez-Aguilar E.","year":"2015","unstructured":"Martinez-Aguilar E.; Gomez-Rodriguez V.; Orbe J.; Rodriguez J.A.; Fern&#xE1;ndez-Alonso L.; Roncal C.; P&#xE1;ramo J.A.; Matrix metalloproteinase 10 is associated with disease severity and mortality in patients with peripheral arterial disease. J Vasc Surg 2015,61(2),428-435","journal-title":"J Vasc Surg"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1373\/clinchem.2006.067439","volume":"52","author":"Nilsson L.","year":"2006","unstructured":"Nilsson L.; Jonasson L.; Nijm J.; Hamsten A.; Eriksson P.; Increased plasma concentration of matrix metalloproteinase-7 in patients with coronary artery disease. Clin Chem 2006,52(8),1522-1527","journal-title":"Clin Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12872-020-01387-3","volume":"20","author":"Moreno-Ajona D.","year":"2020","unstructured":"Moreno-Ajona D.; Irimia P.; Rodr&#xED;guez J.A.; Garc&#xED;a-Velloso M.J.; L&#xF3;pez-Fidalgo J.; Fern&#xE1;ndez-Alonso L.; Grochowitz L.; Mu&#xF1;oz R.; Dom&#xED;nguez P.; G&#xE1;llego-Culler&#xE9; J.; Mart&#xED;nez-Vila E.; Elevated circulating metalloproteinase 7 predicts recurrent cardiovascular events in patients with carotid stenosis: A prospective cohort study. BMC Cardiovasc Disord 2020,20(1),93","journal-title":"BMC Cardiovasc Disord"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1161\/01.CIR.0000041433.94868.12","volume":"106","author":"Uzui H.","year":"2002","unstructured":"Uzui H.; Harpf A.; Liu M.; Doherty T.M.; Shukla A.; Chai N.N.; Tripathi P.V.; Jovinge S.; Wilkin D.J.; Asotra K.; Shah P.K.; Rajavashisth T.B.; Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: Role of activated macrophages and inflammatory cytokines. Circulation 2002,106(24),3024-3030","journal-title":"Circulation"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1161\/CIRCHEARTFAILURE.111.962027","volume":"4","author":"Barasch E.","year":"2011","unstructured":"Barasch E.; Gottdiener J.S.; Aurigemma G.; Kitzman D.W.; Han J.; Kop W.J.; Tracy R.P.; The relationship between serum markers of collagen turnover and cardiovascular outcome in the elderly: The cardiovascular health study. Circ Heart Fail 2011,4(6),733-739","journal-title":"Circ Heart Fail"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1373\/clinchem.2016.270520","volume":"63","author":"Duprez D.A.","year":"2017","unstructured":"Duprez D.A.; Gross M.D.; Sanchez O.A.; Kizer J.R.; Ix J.H.; Lima J.; Tracy R.P.; Jacobs D.R.; Collagen turnover markers in relation to future cardiovascular and noncardiovascular disease: The multi-ethnic study of atherosclerosis. Clin Chem 2017,63(7),1237-1247","journal-title":"Clin Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ijcard.2010.04.034","volume":"150","author":"Manhenke C.","year":"2011","unstructured":"Manhenke C.; &#xD8;rn S.; Squire I.; Radauceanu A.; Alla F.; Zannad F.; Dickstein K.; The prognostic value of circulating markers of collagen turnover after acute myocardial infarction. Int J Cardiol 2011,150(3),277-282","journal-title":"Int J Cardiol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00380-016-0858-2","volume":"32","author":"Otaki Y.","year":"2017","unstructured":"Otaki Y.; Watanabe T.; Takahashi H.; Yamaura G.; Nishiyama S.; Arimoto T.; Shishido T.; Miyamoto T.; Kubota I.; Serum carboxy-terminal telopeptide of type I collagen (I-CTP) is predictive of clinical outcome in peripheral artery disease patients following endovascular therapy. Heart Vessels 2017,32(2),149-156","journal-title":"Heart Vessels"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/joim.12819","volume":"285","author":"Holm Nielsen S.","year":"2019","unstructured":"Holm Nielsen S.; Tengryd C.; Edsfeldt A.; Brix S.; Genovese F.; Bengtsson E.; Karsdal M.; Leeming D.J.; Nilsson J.; Goncalves I.; A biomarker of collagen type I degradation is associated with cardiovascular events and mortality in patients with atherosclerosis. J Intern Med 2019,285(1),118-123","journal-title":"J Intern Med"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.1038\/s41598-018-23458-4","volume":"8","author":"Bertelsen D.M.","year":"2018","unstructured":"Bertelsen D.M.; Neergaard J.S.; Bager C.L.; Nielsen S.H.; Secher N.H.; Svendsen J.H.; Bihlet A.R.; Andersen J.R.; Karsdal M.A.; Christiansen C.; Nielsen H.B.; Matrix metalloproteinase mediated type I collagen degradation is an independent predictor of increased risk of acute myocardial infarction in postmenopausal women. Sci Rep 2018,8(1),5371","journal-title":"Sci Rep"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"636","DOI":"10.5551\/jat.45963","volume":"26","author":"Wang H.","year":"2019","unstructured":"Wang H.; Liu D.; Zhang H.; Investigation of the underlying genes and mechanism of macrophage-enriched ruptured atherosclerotic plaques using bioinformatics method. J Atheroscler Thromb 2019,26(7),636-658","journal-title":"J Atheroscler Thromb"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1161\/01.ATV.19.6.1506","volume":"19","author":"Bode M.K.","year":"1999","unstructured":"Bode M.K.; Mosorin M.; Satta J.; Risteli L.; Juvonen T.; Risteli J.; Complete processing of type III collagen in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 1999,19(6),1506-1511","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/icvts\/ivs421","volume":"16","author":"Kong C.H.","year":"2013","unstructured":"Kong C.H.; Lin X.Y.; Woo C.C.; Wong H.C.; Lee C.N.; Richards A.M.; Sorokin V.A.; Characteristics of aortic wall extracellular matrix in patients with acute myocardial infarction: Tissue microarray detection of collagen I, collagen III and elastin levels. Interact Cardiovasc Thorac Surg 2013,16(1),11-15","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1161\/ATVBAHA.110.208462","volume":"30","author":"Velagaleti R.S.","year":"2010","unstructured":"Velagaleti R.S.; Gona P.; Sundstr&#xF6;m J.; Larson M.G.; Siwik D.; Colucci W.S.; Benjamin E.J.; Vasan R.S.; Relations of biomarkers of extracellular matrix remodeling to incident cardiovascular events and mortality. Arterioscler Thromb Vasc Biol 2010,30(11),2283-2288","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"340","DOI":"10.5551\/jat.45138","volume":"26","author":"Nishimura M.","year":"2019","unstructured":"Nishimura M.; Tokoro T.; Takatani T.; Sato N.; Hashimoto T.; Kobayashi H.; Ono T.; Circulating aminoterminal propeptide of Type III procollagen as a biomarker of cardiovascular events in patients undergoing hemodialysis. J Atheroscler Thromb 2019,26(4),340-350","journal-title":"J Atheroscler Thromb"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1161\/CIRCHEARTFAILURE.113.000403","volume":"6","author":"Eschalier R.","year":"2013","unstructured":"Eschalier R.; Fertin M.; Fay R.; Bauters C.; Zannad F.; Pinet F.; Rossignol P.; Extracellular matrix turnover biomarkers predict long-term left ventricular remodeling after myocardial infarction: Insights from the REVE-2 study. Circ Heart Fail 2013,6(6),1199-1205","journal-title":"Circ Heart Fail"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"194","DOI":"10.18632\/aging.202495","volume":"13","author":"Osokina A.","year":"2021","unstructured":"Osokina A.; Karetnikova V.; Polikutina O.; Ivanova A.; Gruzdeva O.; Dyleva Y.; Kokov A.; Brel N.; Pecherina T.; Barbarash O.; Prognostic potential of cardiac structural and functional parameters and N-terminal propeptide of type III procollagen in predicting cardiac fibrosis one year after myocardial infarction with preserved left ventricular ejection fraction. Aging 2021,13(1),194-203","journal-title":"Aging"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"e114097","DOI":"10.1371\/journal.pone.0114097","volume":"10","author":"Lee C.H.","year":"2015","unstructured":"Lee C.H.; Lee W.C.; Chang S.H.; Wen M.S.; Hung K.C.; The N-terminal propeptide of type III procollagen in patients with acute coronary syndrome: A link between left ventricular end-diastolic pressure and cardiovascular events. PLoS One 2015,10(1),e114097","journal-title":"PLoS One"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"272","DOI":"10.5507\/bp.2013.091","volume":"159","author":"Gao H.","year":"2015","unstructured":"Gao H.; Zhang X.S.; Zhao Q.; Ma L.L.; Wang L.X.; Predictive value of serum collagen biomakers on the outcome of acute myocardial infarction treated with percutaneous coronary intervention. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2015,159(2),272-276","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s00392-019-01500-3","volume":"109","author":"Stienen S.","year":"2020","unstructured":"Stienen S.; Rossignol P.; Barros A.; Girerd N.; Pitt B.; Zannad F.; Ferreira J.P.; Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: Insights from the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS) and early eplerenone treatment in patients with acute st-elevation myocardial infarction without heart failure (REMINDER) trials. Clin Res Cardiol 2020,109(2),194-204","journal-title":"Clin Res Cardiol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1136\/jim-2016-000092","volume":"64","author":"Chang Y.Y.","year":"2016","unstructured":"Chang Y.Y.; Wu Y.W.; Lee J.K.; Lin Y.M.; Lin Y.T.; Kao H.L.; Hung C.S.; Lin H.J.; Lin Y.H.; Effects of 12 weeks of atorvastatin therapy on myocardial fibrosis and circulating fibrosis biomarkers in statin-na&#xEF;ve patients with hypertension with atherosclerosis. J Investig Med 2016,64(7),1194-1199","journal-title":"J Investig Med"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1053\/ejvs.2001.1303","volume":"21","author":"Wilson K.A.","year":"2001","unstructured":"Wilson K.A.; Lindholt J.S.; Hoskins P.R.; Heickendorff L.; Vammen S.; Bradbury A.W.; The relationship between abdominal aortic aneurysm distensibility and serum markers of elastin and collagen metabolism. Eur J Vasc Endovasc Surg 2001,21(2),175-178","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ijcard.2010.02.051","volume":"145","author":"Ormezzano O.","year":"2010","unstructured":"Ormezzano O.; Baguet J.P.; Thony F.; Blin D.; Chavanon O.; Toussaint B.; Trocm&#xE9; C.; Vanzetto G.; Faure P.; Aminoterminal propeptide of type III procollagen (PIIINP) is associated with ascending aortic aneurysm growth rate. Int J Cardiol 2010,145(2),379-380","journal-title":"Int J Cardiol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.3390\/jcm10081718","volume":"10","author":"Nana P.","year":"2021","unstructured":"Nana P.; Dakis K.; Brodis A.; Spanos K.; Kouvelos G.; Circulating biomarkers for the prediction of abdominal aortic aneurysm growth. J Clin Med 2021,10(8),1718","journal-title":"J Clin Med"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s10517-018-4268-6","volume":"165","author":"Murashov I.S.","year":"2018","unstructured":"Murashov I.S.; Volkov A.M.; Kazanskaya G.M.; Kliver E.E.; Savchenko S.V.; Klochkova S.V.; Lushnikova E.L.; Immunohistochemical phenotypes of stable and unstable occlusive atherosclerotic plaques in coronary arteries. Bull Exp Biol Med 2018,165(6),798-802","journal-title":"Bull Exp Biol Med"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0021-9150(86)90172-3","volume":"60","author":"Murata K.","year":"1986","unstructured":"Murata K.; Motayama T.; Kotake C.; Collagen types in various layers of the human aorta and their changes with the atherosclerotic process. Atherosclerosis 1986,60(3),251-262","journal-title":"Atherosclerosis"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0174-173X(85)80024-8","volume":"5","author":"Shekhonin B.V.","year":"1985","unstructured":"Shekhonin B.V.; Domogatsky S.P.; Muzykantov V.R.; Idelson G.L.; Rukosuev V.S.; Distribution of type I, III, IV and V collagen in normal and atherosclerotic human arterial wall: Immunomorphological characteristics. Coll Relat Res 1985,5(4),355-368","journal-title":"Coll Relat Res"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1177\/2047487318758750","volume":"25","author":"Nielsen S.H.","year":"2018","unstructured":"Nielsen S.H.; Mygind N.D.; Michelsen M.M.; Bechsgaard D.F.; Suhrs H.E.; Genovese F.; Nielsen H.B.; Brix S.; Karsdal M.; Prescott E.; Kastrup J.; Accelerated collagen turnover in women with angina pectoris without obstructive coronary artery disease: An iPOWER substudy. Eur J Prev Cardiol 2018,25(7),719-727","journal-title":"Eur J Prev Cardiol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"e009193","DOI":"10.1161\/JAHA.118.009193","volume":"7","author":"Holm Nielsen S.","year":"2018","unstructured":"Holm Nielsen S.; Tengryd C.; Edsfeldt A.; Brix S.; Genovese F.; Bengtsson E.; Karsdal M.; Leeming D.J.; Nilsson J.; Goncalves I.; Markers of basement membrane remodeling are associated with higher mortality in patients with known atherosclerosis. J Am Heart Assoc 2018,7(21),e009193","journal-title":"J Am Heart Assoc"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/emmm.201200237","volume":"4","author":"Rohwedder I.","year":"2012","unstructured":"Rohwedder I.; Montanez E.; Beckmann K.; Bengtsson E.; Dun&#xE9;r P.; Nilsson J.; Soehnlein O.; F&#xE4;ssler R.; Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation. EMBO Mol Med 2012,4(7),564-576","journal-title":"EMBO Mol Med"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/107602960501100107","volume":"11","author":"Ekmekci H.","year":"2005","unstructured":"Ekmekci H.; Ekmekci O.B.; Sonmez H.; Ozturk Z.; Domanic N.; Kokoglu E.; Evaluation of fibronectin, vitronectin, and leptin levels in coronary artery disease: Impacts on thrombosis and thrombolysis. Clin Appl Thromb Hemost 2005,11(1),63-70","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/01.mca.0000066454.28270.fb","volume":"14","author":"&#xD6;rem C.","year":"2003","unstructured":"&#xD6;rem C.; Durmu&#x15F; .; Kl&#xE7;, K.; Baykan, M.; G&#xF6;k&#xE7;e, M.; &#xD6;rem, A.; Topba&#x15F; M. Plasma fibronectin level and its association with coronary artery disease and carotid intima-media thickness. Coron Artery Dis 2003,14(3),219-224","journal-title":"Coron Artery Dis"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0021-9150(00)00490-1","volume":"154","author":"Song K.S.","year":"2001","unstructured":"Song K.S.; Kim H.K.; Shim W.; Jee S.H.; Plasma fibronectin levels in ischemic heart disease. Atherosclerosis 2001,154(2),449-453","journal-title":"Atherosclerosis"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/j.1538-7836.2007.02420.x","volume":"5","author":"Vavalle J.P.","year":"2007","unstructured":"Vavalle J.P.; Wu S.S.; Hughey R.; Madamanchi N.R.; Stouffer G.A.; Plasma fibronectin levels and coronary artery disease. J Thromb Haemost 2007,5(4),864-866","journal-title":"J Thromb Haemost"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1515\/CCLM.2006.008","volume":"44","author":"Zhang Y.","year":"2006","unstructured":"Zhang Y.; Zhou X.; Krepinsky J.C.; Wang C.; Segbo J.; Zheng F.; Association study between fibronectin and coronary heart disease. Clin Chem Lab Med 2006,44(1),37-42","journal-title":"Clin Chem Lab Med"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026623666221024091758","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/210322\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026623666221024091758","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T18:59:22Z","timestamp":1691866762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/210322\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":112,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026623666221024091758","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-06-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}